Physician profile
Amarjit Singh
NPI 1801951280
$2,843.60
in general payments reported to CMS, 2019-2025
23 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $69.13 · 2021: $515 · 2022: $385 · 2023: $266 · 2024: $855 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $630.51 | 2019-2023 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $415.58 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $275.77 | 2021-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $236.87 | 2019-2023 | Verquvo, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.76 | 2024-2025 | Jardiance, Tradjenta |
| Lilly USA, LLC | $146.12 | 2022-2024 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $127.88 | 2019-2021 | |
| Novo Nordisk INC | $125.32 | 2022-2025 | Rybelsus, Ozempic |
| Cook Medical LLC | $84.59 | 2019 | |
| Corcept Therapeutics | $83.25 | 2021-2025 | Korlym |
| Kowa Pharmaceuticals America, INC. | $78.25 | 2024-2025 | Zoryve |
| Pfizer INC. | $74.19 | 2023-2024 | |
| Abbott Laboratories | $59.95 | 2022-2024 | Freestyle Libre 3 |
| Amgen INC. | $58.17 | 2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $53.34 | 2025 | Trelegy Ellipta, Arexvy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $50.51 | 2021 | |
| Exact Sciences Corporation | $45.28 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $23.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.58 | 2019 | |
| G Medical Diagnostic Services, INC. | $13.80 | 2021 | |
| Qol Medical, LLC | $13.61 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amarjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.